Lilly to participate in Citi's 2025 Global Healthcare Conference
Eli Lilly and Company (NYSE:LLY) will participate in Citi's 2025 Global Healthcare Conference on December 2, 2025. Ilya Yuffa, executive vice president and president Lilly USA and Global Customer Capabilities, will appear in a fireside chat at 10:30 a.m. ET.
A live audio webcast will be available in the Webcasts & Presentations section of Lilly's investor website at https://investor.lilly.com/webcasts-and-presentations, and a replay will be accessible on the same page for approximately 90 days.
Eli Lilly and Company (NYSE:LLY) parteciperà al Citi's 2025 Global Healthcare Conference il 2 dicembre 2025. Ilya Yuffa, vicepresidente esecutivo e presidente di Lilly USA e Global Customer Capabilities, parteciperà a un colloquio informale alle 10:30 a.m. ET.
Una trasmissione audio in diretta sarà disponibile nella sezione Webcasts & Presentations del sito degli investitori di Lilly all'indirizzo https://investor.lilly.com/webcasts-and-presentations, e una replica sarà accessibile sulla stessa pagina per circa 90 giorni.
Eli Lilly and Company (NYSE:LLY) participará en Citi's 2025 Global Healthcare Conference el 2 de diciembre de 2025. Ilya Yuffa, vicepresidente ejecutivo y presidente de Lilly USA y Global Customer Capabilities, aparecerá en una charla informal a las 10:30 a. m. ET.
Una transmisión de audio en directo estará disponible en la sección Webcasts & Presentations del sitio para inversores de Lilly en https://investor.lilly.com/webcasts-and-presentations, y una repetición estará accesible en la misma página por aproximadamente 90 días.
Eli Lilly and Company (NYSE:LLY)는 Citi's 2025 Global Healthcare Conference에 2025년 12월 2일에 참가할 예정입니다. Ilya Yuffa, 부사장 겸 Lilly USA 및 Global Customer Capabilities 사장은 오전 10:30 ET에 파이어사이드 채팅 형식의 대담에 출연합니다.
라이브 오디오 생중계는 Lilly의 투자자 웹사이트 Webcasts & Presentations 섹션에서 https://investor.lilly.com/webcasts-and-presentations로 제공되며, 같은 페이지에서 약 90일간 재생이 가능합니다.
Eli Lilly and Company (NYSE:LLY) participera au Citi's 2025 Global Healthcare Conference le 2 décembre 2025. Ilya Yuffa, vice-président exécutif et président de Lilly USA et Global Customer Capabilities, apparaîtra lors d'un entretien au coin du feu (fireside chat) à 10:30 a.m. ET.
Une webdiffusion audio en direct sera disponible dans la section Webcasts & Presentations du site investisseurs de Lilly à l'adresse https://investor.lilly.com/webcasts-and-presentations, et une rediffusion sera accessible sur la même page pendant environ 90 jours.
Eli Lilly and Company (NYSE:LLY) wird am Citi's 2025 Global Healthcare Conference am 2. Dezember 2025 teilnehmen. Ilya Yuffa, Executive Vice President und Präsident von Lilly USA und Global Customer Capabilities, wird an einem Fireside-Chat um 10:30 Uhr ET teilnehmen.
Eine Live-Audio-Webcast-Übertragung wird im Abschnitt Webcasts & Presentations der Investorenseite von Lilly unter https://investor.lilly.com/webcasts-and-presentations verfügbar sein, und eine Wiederholung wird auf derselben Seite für ca. 90 Tage abrufbar sein.
شركة ليلي وإلى حد كبير (NYSE:LLY) ستشارك في Citi's 2025 Global Healthcare Conference في 2 ديسمبر 2025. سيظهر إياليا يوفا، نائب الرئيس التنفيذي ورئيس Lilly USA والقدرات العالمية للعملاء، في جلسة حوار غير رسمي عند 10:30 صباحاً بتوقيت شرق الولايات المتحدة.
سيكون هناك بث صوتي مباشر متاح في قسم Webcasts & Presentations على موقع ليلي للمستثمرين على العنوان https://investor.lilly.com/webcasts-and-presentations، وسيكون بالإمكان الوصول إلى إعادة العرض نفسه على نفس الصفحة لمدة تقارب 90 يوماً.
- None.
- None.
A live audio webcast will be available on the "Webcasts & Presentations" section of Lilly's investor website at https://investor.lilly.com/webcasts-and-presentations. A replay of the presentation will be available on this same website for approximately 90 days.
About Lilly
Lilly is a medicine company turning science into healing to make life better for people around the world. We've been pioneering life-changing discoveries for nearly 150 years, and today our medicines help tens of millions of people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world's most significant health challenges: redefining diabetes care; treating obesity and curtailing its most devastating long-term effects; advancing the fight against Alzheimer's disease; providing solutions to some of the most debilitating immune system disorders; and transforming the most difficult-to-treat cancers into manageable diseases. With each step toward a healthier world, we're motivated by one thing: making life better for millions more people. That includes delivering innovative clinical trials that reflect the diversity of our world and working to ensure our medicines are accessible and affordable. To learn more, visit Lilly.com and Lilly.com/news, or follow us on Facebook, Instagram, and LinkedIn. F-LLY
Trademarks and Trade Names
All trademarks or trade names referred to in this press release are the property of the company, or, to the extent trademarks or trade names belonging to other companies are references in this press release, the property of their respective owners. Solely for convenience, the trademarks and trade names in this press release are referred to without the ® and ™ symbols, but such references should not be construed as any indicator that the company or, to the extent applicable, their respective owners will not assert, to the fullest extent under applicable law, the company's or their rights thereto. We do not intend the use or display of other companies' trademarks and trade names to imply a relationship with, or endorsement or sponsorship of us by, any other companies.
|
Refer to: |
Ashley Hennessey; gentry_ashley_jo@lilly.com; 317-416-4363 (Media) |
|
|
Michael Czapar; czapar_michael_c@lilly.com; 317-617-0983 (Investors) |
View original content to download multimedia:https://www.prnewswire.com/news-releases/lilly-to-participate-in-citis-2025-global-healthcare-conference-302617897.html
SOURCE Eli Lilly and Company